Renin-angiotensin blocker use is associated with improved cardiovascular mortality in Indian patients with mild-moderate chronic kidney disease—findings from the ICKD study

INTRODUCTION: Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) are the antihypertensive drug class of choice in patients with chronic kidney disease (CKD). Head-to-head comparisons of the renal or non-renal outcomes between ACEI/ARB users and nonusers have not...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasad, Narayan, Yadav, Ashok Kumar, Kundu, Monica, Jaryal, Ajay, Sircar, Dipankar, Modi, Gopesh, Sahay, Manisha, Gopalakrishnan, Natarajan, Vikrant, Sanjay, Varughese, Santosh, Baid-Agrawal, Seema, Singh, Shivendra, Gang, Sishir, Parameswaran, Sreejith, Ghosh, Arpita, Kumar, Vivek, Jha, Vivekanand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807808/
https://www.ncbi.nlm.nih.gov/pubmed/36606058
http://dx.doi.org/10.3389/fmed.2022.1060148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807808/
https://www.ncbi.nlm.nih.gov/pubmed/36606058
http://dx.doi.org/10.3389/fmed.2022.1060148

Ejemplares similares